Reboot #159 Atrial Fibrillation

Aug 09, 2021, 07:00 AM

Enjoy this Curbsiders classic and stay tuned this Wednesday, August 11, 2021 for a brand new Afib Triple Distilled version.

Take control of atrial fibrillation with expert insights and pearls from cardiologist, Dr. James Furgerson, in this jam-packed episode! You’ll learn why atrial fibrillation is such a big deal, how to diagnose it, how to treat it and when to call in for reinforcements. Dr. James Furgerson, MD  is a cardiologist from San Antonio, Texas with over 20 years in academics. Buckle up – This episode is going to send your heart racing! You might even skip a beat! 

Credits
  • Writer and Producer: Cyrus Askin MD
  • Infographic: Cyrus Askin MD
  • Cover Art: Cyrus Askin MD
  • Hosts: Matthew Watto MD, Paul Williams MD, Cyrus Askin MD
  • Editors: Matthew Watto MD
  • Guest: James Furgerson MD


Sponsor: American College of Physicians acponline.org/100curb
ACP CME 100 virtual video package includes 100 hours of practice-changing updates by expert faculty from Internal Medicine Meeting 2021 acponline.org/100CURB. Plus enjoy an exclusive: 25 bonus CME sessions and access until June 1, 2024!


Sponsor: Panacea Financial
panaceafinancial.com
Visit panaceafinancial.com today to open your account and join a bank built with you in mind. 


Time Stamps*
*Note:
Time stamps refer to ad-free version 
  • 00:00 Intro, disclaimer and guest bio
  • 03:45 Guest one liner, a bit on physician well-being and some other randomness
  • 08:15 A case of palpitations; risk factors for atrial fibrillation
  • 12:17 Subclinical atrial fibrillation, overdiagnosis of atrial fibrillation; How much afib burden matters? 
  • 15:08 Case summary and next steps in initial work up
  • 18:48 Counseling patient about atrial fibrillation and its consequences
  • 21:40 Ischemic heart disease and atrial fibrillation
  • 24:17 Recap of diagnosis, initial work up and risk stratification in atrial fibrillation
  • 25:25 Rate versus rhythm control; AFFIRM trial
  • 30:50 Strict versus lenient rate control;  RACE trial
  • 33:30 Deciding on rate versus rhythm control; Downside of antiarrhythmic therapies; When to switch from rate to rhythm control strategy
  • 36:52 Ablation for atrial fibrillation; CASTLE-AF, CABANA trials
  • 40:40 When to refer to cardiology and electrophysiology
  • 42:42 Choice of agent for anticoagulation and latest guidelines for atrial fibrillation; New definition for valvular atrial fibrillation
  • 45:22 DOACs in CKD and some other nuances in choice of agent
  • 52:27 Bleeding and anticoagulation
  • 58:38 Cardioversion for atrial fibrillation (initial versus delayed)
  • 63:32 Anticoagulation before and after cardioversion
  • 67:48 Lifestyles measures for atrial fibrillation
  • 70:45 Atrial fibrillation during critical illness, after CABG and in hyperthyroidism
  • 74:12 Aspirin monotherapy is not appropriate for atrial fibrillation
  • 76:42 Take home points
  • 78:50 Outro